POC(Point of Care) ºÐÀÚÁø´Ü ½ÃÀå º¸°í¼­ : Á¦Ç° ¹× ¼­ºñ½ºº°, ±â¼úº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°(2025-2033³â)
Point of Care Molecular Diagnostics Market Report by Product and Service, Technology, Application, End User, and Region 2025-2033
»óǰÄÚµå : 1701828
¸®¼­Ä¡»ç : IMARC Group
¹ßÇàÀÏ : 2025³â 04¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 139 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,339,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,786,000
PDF & Excel (5 User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 7,233,000
PDF & Excel (Corporate License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ POC(Point of Care) ºÐÀÚÁø´Ü ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 40¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº ½ÃÀåÀÌ 2033³â±îÁö 87¾ï ´Þ·¯¿¡ ´ÞÇϸç, 2025-2033³âÀÇ ¼ºÀå·ü(CAGR)Àº 8.78%¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. °¨¿°¼º ÁúȯÀÇ ¹ßº´·ü Áõ°¡¿Í ÀÇ·á ½Ã¼³ÀÇ ±Þ¼ÓÇÑ ¹ßÀüÀÌ ½ÃÀå ¼ºÀåÀ» Å©°Ô ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÇöÀåÁø´Ü(POC) ºÐÀÚÁø´ÜÀº Àǻ簡 °¨¿°¼º ÁúȯÀÇ Áø´Ü ¹× °ËÃâÀ» À§ÇØ ½ÃÇàÇÏ´Â °Ë»ç¸¦ ¸»ÇÕ´Ï´Ù. Ç÷¾×ÇÐ, ÀÓ½Å, ºÒÀÓ, ºÒÀÓ, °¨¿°, ¼Òº¯ °Ë»ç ŰƮ, ½ÉÀå ´ë»ç ¹× Æ÷µµ´ç ¸ð´ÏÅ͸µ Àåºñ µîÀ» Æ÷ÇÔÇϸç, POC ºÐÀÚÁø´Ü¹ýÀº °¨¿°, ¹Ì¼¼ ÀÜ·ù º´º¯, ¼ÒÈ­±â ÁúȯÀÇ ½Äº°, Çì¸ð±Û·Îºó ¹× ´ëº¯ ÀáÇ÷ ¸ð´ÏÅ͸µ, ¾à¹° ¹× ¾à¹° Ŭ·¡½ºÀÇ ´ë»ç ´É·Â ÆÇ´Ü µî¿¡ ³Î¸® »ç¿ëµË´Ï´Ù. µî¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °Ë»ç´Â º¸´Ù ºü¸¥ °á°ú¸¦ Á¦°øÇϰí, ¿ÀÁø Ä¡·á¿Í °ü·ÃµÈ ÇÕº´ÁõÀ» ÁÙÀ̰í, °¨¿° °ü¸® Á¶Ä¡¸¦ °³¼±ÇÕ´Ï´Ù. ±× °á°ú, POC ºÐÀÚÁø´Ü¹ýÀº º´¿ø, ÁßȯÀÚ½Ç(ICU), ¿¬±¸±â°ü, Áø·á¼Ò, ºÐ»êÇü °Ë»ç½Ç, ÀçÅà ¿ä¾ç½Ã¼³ µî¿¡¼­ Æø³Ð°Ô Àû¿ëµÇ°í ÀÖ½À´Ï´Ù.

POC(Point-Of-Care) ºÐÀÚÁø´Ü ½ÃÀå µ¿Çâ :

POC ºÐÀÚÁø´Ü Å×½ºÆ®´Â µ¶°¨, °áÇÙ, Àΰ£¸é¿ª°áÇ̹ÙÀÌ·¯½º(HIV), Ŭ¶ó¹Ìµð¾Æ, °£¿° µî °¨¿°¼º ÁúȯÀ» °ü¸®ÇÏ´Â µ¥ ³Î¸® »ç¿ëµÇ´Â ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼ÇÀ¸·Î, Àü ¼¼°è¿¡¼­ Àü¿°º´ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå Àü¸ÁÀº ¹à½À´Ï´Ù. ¶ÇÇÑ COVID-19ÀÇ È®»êÀ» È¿°úÀûÀ¸·Î °ü¸®ÇÏ°í ¾ïÁ¦Çϱâ À§ÇÑ PCR °Ë»ç ŰƮ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡µµ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¼ÒÇüÈ­, ³ª³ëÅ×Å©³î·¯Áö, ¸¶ÀÌÅ©·ÎÇ÷çÀ̵ñ½º°øÇÐÀ» Ȱ¿ëÇÏ¿© Àúºñ¿ë, »ç¿ëÀÚ Ä£È­ÀûÀÎ °í°¨µµ ºÐÀÚÁø´Ü Å×½ºÆ®¸¦ °³¹ßÇϱâ À§ÇÑ ¼ÒÇüÈ­, ³ª³ëÅ×Å©³î·¯Áö, ¸¶ÀÌÅ©·ÎÇ÷çÀ̵ñ½º°øÇÐÀÇ Ã¤ÅÃÀÌ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·á ÀÎÇÁ¶ó¸¦ °³¼±ÇÏ°í ºÐÀÚÁø´Ü ¿ª·®À» °­È­Çϱâ À§ÇÑ ´Ù¾çÇÑ Á¤ºÎ ±¸»óÀÇ ½ÃÇàÀº ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ µ¥¿Á½Ã¸®º¸ÇÙ»ê(DNA) ½ÃÄö½ÌÀÇ ±Þ¼ÓÇÑ ¹ßÀü, ÷´Ü Ä¡·á ¹× Áø´Ü °Ë»ç¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, Ŭ¶ó¿ìµå ¿¬°áÇü POC Áø´Ü ±â¼úÀÇ ÃÖ±Ù °³¹ß µ¿Çâ µîÀÌ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ¼­·Ð

Á¦5Àå ¼¼°èÀÇ POC(Point of Care) ºÐÀÚÁø´Ü ½ÃÀå

Á¦6Àå ½ÃÀå ³»¿ª : Á¦Ç°¡¤¼­ºñ½ºº°

Á¦7Àå ½ÃÀå ³»¿ª : ±â¼úº°

Á¦8Àå ½ÃÀå ³»¿ª : ¿ëµµº°

Á¦9Àå ½ÃÀå ³»¿ª : ÃÖÁ¾»ç¿ëÀÚº°

Á¦10Àå ½ÃÀå ³»¿ª : Áö¿ªº°

Á¦11Àå SWOT ºÐ¼®

Á¦12Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦13Àå Porter's Five Forces ºÐ¼®

Á¦14Àå °¡°Ý ºÐ¼®

Á¦15Àå °æÀï ±¸µµ

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global point of care molecular diagnostics market size reached USD 4.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.7 Billion by 2033, exhibiting a growth rate (CAGR) of 8.78% during 2025-2033. The increasing incidence of infectious diseases paired with rapid development in healthcare facilities is significantly driving the market growth.

Point-of-care (POC) molecular diagnostics refer to tests performed by physicians to diagnose and detect infectious diseases. It includes hematology, pregnancy, fertility, infectious diseases, urinalysis testing kits, and cardiometabolic and glucose monitoring devices. POC molecular diagnostics is widely used for identifying infectious agents, minimal residual disease, and gastrointestinal disorders, monitoring hemoglobin and fecal occult blood, and determining a patient's ability to metabolize a drug or drug class. These tests offer faster results, reduce complications associated with mistreatment, and improve infection control measures. As a result, POC molecular diagnostics finds extensive applications in hospitals, intensive care units (ICUs), research institutes, clinics, decentralized laboratories, and homecare facilities.

Point of Care Molecular Diagnostics Market Trends:

The increasing prevalence of infectious diseases across the globe is creating a positive outlook for the market. POC molecular diagnostic tests is a cost-effective solution widely used to manage infectious diseases, such as flu, tuberculosis, human immunodeficiency virus (HIV) infection, chlamydia, and hepatitis. Additionally, the rising demand for PCR test kits to effectively manage and control the spread of COVID-19 is acting as another growth-inducing factor. Furthermore, the adoption of miniaturization, nanotechnology, and microfluidics to develop low-cost, user-friendly, and highly sensitive molecular diagnostic tests is providing an impetus to the market growth. Moreover, the implementation of various government initiatives toward improving healthcare infrastructure and enhancing molecular diagnostic capabilities is positively influencing the market growth. Other factors, including rapid advancements in deoxyribonucleic acid (DNA) sequencing, rising awareness regarding advanced therapeutic and diagnostic tests, increasing geriatric population, and recent developments in cloud-connected POC diagnostic technologies, are anticipated to drive the market growth.

Key Market Segmentation:

Breakup by Product and Service:

Breakup by Technology:

Breakup by Application:

Breakup by End User:

Breakup by Region:

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, Binx Health Inc., Co-Diagnostics Inc., F. Hoffmann-La Roche Ltd, Gene STAT Molecular Diagnostics LLC, Hemocue AB (Danaher Corporation), Meridian Bioscience Inc., Molbio Diagnostics Private Limited, Quidel Corporation, Siemens Healthcare GmbH (Siemens AG), Thermo Fisher Scientific Inc. and Visby Medical Inc.

Key Questions Answered in This Report

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Point of Care Molecular Diagnostics Market

6 Market Breakup by Product and Service

7 Market Breakup by Technology

8 Market Breakup by Application

9 Market Breakup by End User

10 Market Breakup by Region

11 SWOT Analysis

12 Value Chain Analysis

13 Porters Five Forces Analysis

14 Price Analysis

15 Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â